Does Vapotherm, Inc. (VAPO) Have Any Gas After Today’s Huge Decline?

The stock of Vapotherm, Inc. (NYSE:VAPO) is a huge mover today! The stock decreased 3.92% or $0.37 during the last trading session, reaching $9.06. About 195,334 shares traded or 24.79% up from the average. Vapotherm, Inc. (NYSE:VAPO) has 0.00% since September 13, 2018 and is . It has by 0.00% the S&P500.
The move comes after 6 months negative chart setup for the $158.55 million company. It was reported on Sep, 13 by Barchart.com. We have $8.61 PT which if reached, will make NYSE:VAPO worth $7.93M less.

Analysts await Vapotherm, Inc. (NYSE:VAPO) to report earnings on November, 4. After $-0.76 actual earnings per share reported by Vapotherm, Inc. for the previous quarter, Wall Street now forecasts 1.32 % negative EPS growth.

More notable recent Vapotherm, Inc. (NYSE:VAPO) news were published by: Seekingalpha.com which released: “Vapothem: Revenue Growth Of 18.16% Y/Y, But Upside Is Limited – Seeking Alpha” on November 08, 2018, also Businesswire.com with their article: “Clinical Study Shows Vapotherm’s New IntellO2â„¢ Module for Precision Flow® System Significantly Improves Maintenance of Premature Neonates in Target Oxygenation Range – Business Wire” published on December 04, 2018, Finance.Yahoo.com published: “What Percentage Of Vapotherm, Inc. (NYSE:VAPO) Shares Do Insiders Own? – Yahoo Finance” on August 09, 2019. More interesting news about Vapotherm, Inc. (NYSE:VAPO) were released by: Seekingalpha.com and their article: “Vapotherm prices initial public offering – Seeking Alpha” published on November 14, 2018 as well as Seekingalpha.com‘s news article titled: “Stocks To Watch: China Redux, 13F Season And Blockchain Blockbuster – Seeking Alpha” with publication date: May 11, 2019.

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company has market cap of $158.55 million. The firm offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It currently has negative earnings. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.